Education
About Us
Working with TipRanks
Follow Us
LivaNova PLC (LIVN)
NASDAQ:LIVN
LIVN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$43.15 - $64.48
Previous CloseN/A
Volume66.13K
Average Volume (3M)464.06K
Market Cap
$2.58B
Enterprise Value$2.88B
Total Cash (Recent Filing)$47.20M
Total Debt (Recent Filing)$168.30M
Price to Earnings (P/E)111.3
Beta1.20
Next Earnings
Feb 25, 2025EPS Estimate
0.8Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.43
Shares Outstanding54,300,835
10 Day Avg. Volume440,019
30 Day Avg. Volume464,059
Standard Deviation0.11
R-Squared0.25
Alpha-0.01
Financial Highlights & Ratios
PEG Ratio0.16
Price to Book (P/B)N/A
Price to Sales (P/S)2.07
Price to Cash Flow (P/CF)12.60
P/FCF Ratio19.60
Enterprise Value/Market Cap1.12
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit3.74
Enterprise Value/Ebitda49.62
Forecast
1Y Price Target
$65.33Price Target Upside56.93% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
---
LivaNova News
PremiumCompany Announcements
LivaNova PLC Reports Strong Growth Amid Challenges---
Bulls Say, Bears Say
Bulls Say
New Product CycleLIVN is benefiting from its Essenz new product cycle with strong sales growth in the heart-lung machine market.
Bears Say
Epilepsy Segment ConcernsThere are execution issues affecting the global epilepsy market, with significant personnel changes and a decline in performance.
Litigation ImpactThe sell-off in shares was more linked to disclosure that the Italian Supreme Court will hold a public hearing regarding the ongoing SNIA litigation, where a resolution could come sooner than expected, impacting EPS negatively.
---
Ownership Overview
0.27% Insiders
28.12% Mutual Funds
30.62% Other Institutional Investors
21.73% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
LIVN FAQ
What was LivaNova PLC’s price range in the past 12 months?
LivaNova PLC lowest stock price was $43.15 and its highest was $64.47 in the past 12 months.
What is LivaNova PLC’s market cap?
LivaNova PLC’s market cap is $2.58B.
When is LivaNova PLC’s upcoming earnings report date?
LivaNova PLC’s upcoming earnings report date is Feb 25, 2025 which is 6 days ago.
How were LivaNova PLC’s earnings last quarter?
LivaNova PLC released its earnings results on Feb 25, 2025. The company reported $0.81 earnings per share for the quarter, beating the consensus estimate of $0.801 by $0.009.
Is LivaNova PLC overvalued?
According to Wall Street analysts LivaNova PLC’s price is currently Undervalued.
Does LivaNova PLC pay dividends?
LivaNova PLC does not currently pay dividends.
What is LivaNova PLC’s EPS estimate?
LivaNova PLC’s EPS estimate is 0.8.
How many shares outstanding does LivaNova PLC have?
LivaNova PLC has 54,300,835 shares outstanding.
What happened to LivaNova PLC’s price movement after its last earnings report?
LivaNova PLC reported an EPS of $0.81 in its last earnings report, beating expectations of $0.801. Following the earnings report the stock price went down -15.758%.
Which hedge fund is a major shareholder of LivaNova PLC?
Currently, no hedge funds are holding shares in LIVN
---
LivaNova Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$65.33 (56.93% Upside)
$65.33 (56.93% Upside)
Blogger Sentiment
Bullish
LIVN Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 1.2M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $63.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 6.3%
Last 30 Days ▼ 6.3%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-24.43%
12-Months-Change
Fundamentals
Return on Equity
4.79%
Trailing 12-Months
Asset Growth
3.16%
Trailing 12-Months
Company Description
LivaNova PLC
LivaNova Plc is a global medical technology company, which engages in the development and delivery of important therapeutic solutions for the benefit of patients, healthcare professionals and healthcare systems. It operates through the following segments: Cardiovascular, Neuromodulation, and Others. The Cardiovascular segment develops, produces, and sells cardiopulmonary products, heart valves, and advanced circulatory support products. The Neuromodulation segment designs and markets NM-based medical devices for the treatment of epilepsy, depression, and obstructive sleep apnea. The Other segment consists of company's shared service expenses for finance, legal, human resources, information technology, and new ventures. Its products include VNS therapy system. oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, and cannulae. The company was founded on February 20, 2015 and is headquartered in London, the United Kingdom.
---
LIVN Company Deck
---
LIVN Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected strong financial performance with significant growth in key segments and positive clinical milestones. However, challenges in the epilepsy segment and uncertainties regarding SNIA litigation and tax rate increases were noted.Read More>---
LIVN Stock 12 Month Forecast
Average Price Target
$65.33
▲(56.93% Upside)
Technical Analysis
Boston Scientific
―
Edwards Lifesciences
―
Medtronic
―
Stryker
―
Zimmer Biomet Holdings
―
Best Analysts Covering LIVN
1 Year
1 Year Success Rate
7/20 ratings generated profit
1 Year Average Return
-11.16%
assigned a buy rating 4 months ago
Copying Adam Maeder's trades and holding each position for 1 Year would result in 35.00% of your transactions generating a profit, with an average return of -11.16% per trade.
---